



Cannabis in NY has already reached $4 billion in legal sales. Understand what this milestone reveals about the regulated market and its upcoming challenges.
Executive Milena Rocha will discuss the role of pharmaceutical retail in access to medical cannabis during an event bringing together representatives from Anvisa and Embrapa.
The EU is advancing common rules for hemp, including flowers and leaves. Understand what the proposal entails and what is still needed for it to become law.
Understand how WEpayments integrates payments, foreign exchange, and technology to simplify operations and drive growth in the medical cannabis market.
Cannabis cultivation in Brazil: genetics, costs, and regulation will be under debate at Cannabis Connection 2026. Learn more on Portal Sechat.
A document from Colombia's FNE distinguishes between controlled and non-controlled products and details traceability requirements. Learn more on Portal Sechat.
A lawyer explains how the tax reform affects cannabis companies, compounding pharmacies, and imports via RDC 660. Understand what changes.
Sandro Nogueira, CEO of Memphis Logistics, warns that the potential removal of tax benefits could raise the cost of imported cannabis and hinder patients' access to treatment.
Discover how sanitary regulations and CBD costs affect the sector. Learn all about the future of medical cannabis at Cannabis Connection 2026.
Note from Paraguay's DINAVISA establishes requirements for shipments to Brazilian patients and updates a case that exposed regulatory hurdles. Read on Sechat
A proposal in Puerto Rico could reduce the number of eligible medical cannabis patients by up to 95% and affect public services. Learn more
Medical cannabis imports grow 27% in the first half of 2026. See the figures for RDC 660 and what will be discussed at Cannabis Connection.